Paper34268564
Autotransplantation of the ovarian cortex after in-vitro activation for infertility treatment: a shortened procedure.
Zhai J and 18 others. Hum Reprod, 2021. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Autotransplantation of the ovarian cortex after in-vitro activation for infertility treatment: a shortened procedure. Papers, record 34268564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34268564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Autotransplantation of the ovarian cortex after in-vitro activation for infertility treatment: a shortened procedure.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Infertility, Female | Major topic |
| Ovary | Major topic |
| Animals | |
| Female | |
| Humans | |
| Mice | |
| Ovarian Follicle | |
| Prospective Studies | |
| Transplantation, Autologous |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41509147 | Clinical practice guidelines for the management of differences of sex development in Japan. | Clin Pediatr Endocrinol | 2026 | https://conductscience.org/library/papers/41509147 | PubMed |
| 41338999 | Clinical practice guidelines for the management of differences of sex development in Japan. | Endocr J | 2026 | https://conductscience.org/library/papers/41338999 | PubMed |
| 40890824 | Engineering modification of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorates polycystic ovary syndrome by enhancing the ovarian environment and regulating follicular development. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40890824 | PubMed |
| 40533774 | The risk factors, pathogenesis and treatment of premature ovarian insufficiency. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/40533774 | PubMed |
| 39872394 | Follicular fluid-derived exosomes rejuvenate ovarian aging through miR-320a-3p-mediated FOXQ1 inhibition. | Life Med | 2024 | https://conductscience.org/library/papers/39872394 | PubMed |
| 39430241 | Theophylline derivatives promote primordial follicle activation via cAMP-PI3K/Akt pathway and ameliorate fertility deficits in naturally aged mice. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/39430241 | PubMed |
| 38532230 | Enhancing Oocyte Quality in Aging Mice: Insights from Mesenchymal Stem Cell Therapy and FOXO3a Signaling Pathway Activation. | Reprod Sci | 2024 | https://conductscience.org/library/papers/38532230 | PubMed |
| 38315420 | Basal characteristics of patients who responded to Ovarian Fragmentation for Follicular Activation (OFFA) or In Vitro Activation (IVA): a systematic review and meta-analysis. | J Assist Reprod Genet | 2024 | https://conductscience.org/library/papers/38315420 | PubMed |
| 37834198 | Facilitation of Ovarian Response by Mechanical Force-Latest Insight on Fertility Improvement in Women with Poor Ovarian Response or Primary Ovarian Insufficiency. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834198 | PubMed |
| 37460850 | Potential Therapeutic Options for Premature Ovarian Insufficiency: Experimental and Clinical Evidence. | Reprod Sci | 2023 | https://conductscience.org/library/papers/37460850 | PubMed |
| 37171807 | Making a good egg: human oocyte health, aging, and in vitro development. | Physiol Rev | 2023 | https://conductscience.org/library/papers/37171807 | PubMed |
| 36926197 | Mechanisms of primordial follicle activation and new pregnancy opportunity for premature ovarian failure patients. | Front Physiol | 2023 | https://conductscience.org/library/papers/36926197 | PubMed |
| 35929517 | Effects and potential mechanism of Ca2+/calmodulin‑dependent protein kinase II pathway inhibitor KN93 on the development of ovarian follicle. | Int J Mol Med | 2022 | https://conductscience.org/library/papers/35929517 | PubMed |
| 35774306 | In vivo evaluation of endometrium through dual-modality intrauterine endoscopy. | Biomed Opt Express | 2022 | https://conductscience.org/library/papers/35774306 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PIK3R1 | 5295 | PubTator's text mining | https://conductscience.org/library/genes/5295 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| ChiCTR | ChiCTR2000030872 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34268564
GET https://conductscience.org/api/papers/v1/34268564/authors